Published in Women's Health Weekly, November 17th, 2011
"Here, we showed that naringin perturbs osteoclast formation and bone resorption by inhibiting RANK-mediated NF-'B and ERK signaling....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.